0001356710-20-000002.txt : 20201218
0001356710-20-000002.hdr.sgml : 20201218
20201218162401
ACCESSION NUMBER: 0001356710-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201216
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weldon Steven W
CENTRAL INDEX KEY: 0001356710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 201400901
MAIL ADDRESS:
STREET 1: 7280 WESTPOINTE BLVD
STREET 2: APT 831
CITY: ORLANDO
STATE: FL
ZIP: 32835
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9350 WILSHIRE BLVD.
STREET 2: SUITE 203
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 9350 WILSHIRE BLVD.
STREET 2: SUITE 203
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-12-16
0
0000109657
GT Biopharma, Inc.
GTBP
0001356710
Weldon Steven W
401 EAST JACKSON STREET
SUITE 2340
TAMPA
FL
33602
0
0
0
1
Former Officer and Director
Common Stock
2020-12-16
4
S
0
50000
0.3
D
4053700
D
Common Stock
2020-12-17
4
S
0
50000
0.3
D
4003700
D
Common Stock
2020-12-17
4
S
0
50000
0.31
D
3953700
D
Common Stock
2020-12-18
4
S
0
50000
0.3
D
3903700
D
. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.
Steven Weldon
2020-12-18